Study Evaluating the Effect of Isonatremic Dialysis Treatment in Chronic Kidney Disease Patients on Dialysis
NCT ID: NCT04809493
Last Updated: 2022-04-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2021-03-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* control of interdialytic weight gain
* perdialytic tolerance in terms of adverse events occurring during all of the sessions of the study
* body composition and thirst measured monthly during the 4 months of follow-up.
* tolerance to treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis
NCT04810338
Ionized Magnesium Balance During Hemodialysis Session
NCT05337436
Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients
NCT01327391
Comparison of the Impact of Dialysis Treatment Type on Patient Survival
NCT00510549
Impact of Hemodialysis on Cutaneo-muscular Electrical Impedance
NCT04892745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients will be receiving conventional dialysis
Patients will be receiving conventional dialysis treatment followed by isonatremic dialysis treatment during an observational period of 2 months for each treatment
Conventional dialysis treatment
Conventional dialysis treatment
Isonatremic dialysis treatment
Isonatremic dialysis treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional dialysis treatment
Conventional dialysis treatment
Isonatremic dialysis treatment
Isonatremic dialysis treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With plasma sodium concentration between 130 and 140 mmol/L
* Anuric
* Patient dialysed with dialysis machine allowing isonatremic dialysis treatment
Exclusion Criteria
* Pacemaker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Paul CRISTOL, Prof
Role: STUDY_DIRECTOR
UH MONTPELLIER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Uhmontpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL20_0659
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.